Among the patients who experienced adverse reactions, 26 (57.8%) had elevated liver enzyme levels, 15 (57.7%) returned to normal levels after drug discontinuation, and 8 (30.8%) showed a decreasing trend.
← all excerpts
Impact of early and delayed azvudine administration on COVID-19 mortality: a retrospective study.
1
—
—